Company
Milestone

2019
With a vision of helping the world prepare for the next pandemic, Avalon BioMedical Management Limited (Parent company of Avalon SteriTech) partners with MTR Corporation collaboration to co-develop and commercialize disinfection solutions.
Jan 2020
Avalon SteriTech is founded.
Feb 2020
With the first wave of the pandemic peaking in Hong Kong, a fleet of 20 VHP Robots are being deployed across MTR depots and stations to perform daily disinfection.
Mar 2021
Avalon SteriTech and SoftBank Robotics Group set up a Joint Venture to develop and promote innovative public healthcare and hygiene solutions.

Together, they have launched Whiz Gambit, the 2-in-1 AI-powered cleaning and disinfection robotic solution.
Jan 2022
Whiz Gambit receives the Innovation Honoree at the CES 2022 Innovation Awards.
Apr 2022
SoftBank Robotics Group makes strategic equity investment in Avalon SteriTech, marking its first investment in Hong Kong.
Jun 2022
Avalon SteriTech establishes strategic partnership with MicroSafe® with the objective of delivering safe and eco-friendly disinfection solutions.
Dec 2022
Avalon SteriTech raises US$9M in Pre-Series A funding.
Apr 2023
Avalon SteriTech is certified with ISO 9001 and ISO 13485 standards.
Now
Avalon SteriTech harnesses digital capabilities to transform traditional cleaning and drive meaningful business impact.
2019
Avalon BioMedical Management Limited (Parent company of Avalon SteriTech) partners with MTR Corporation to co-develop and commercialize disinfection solutions.
Jan 2020
Avalon SteriTech is founded.
Feb 2020
With the first wave of the pandemic peaking in Hong Kong, a fleet of 20 VHP Robots is being deployed across MTR depots and stations.
Mar 2021
Avalon SteriTech and SoftBank Robotics Group set up a Joint Venture to develop innovative public healthcare and hygiene solutions.

Together, they have launched Whiz Gambit, the 2-in-1 AI-powered cleaning and disinfection robot.
Jan 2022
Whiz Gambit receives the Innovation Honoree at the CES 2022 Innovation Awards.
Apr 2022
SoftBank Robotics Group makes strategic equity investment in Avalon SteriTech, marking its first investment in Hong Kong.
Jun 2022
Avalon SteriTech establishes strategic partnership with MicroSafe® to deliver safe and eco-friendly disinfection solutions.
Dec 2022
Avalon SteriTech raises US$9M in Pre-Series A funding
Apr 2023
Avalon SteriTech is certified with ISO 9001 and ISO 13485 standards.
Now
Avalon SteriTech harnesses digital capabilities to transform traditional cleaning and drive meaningful business impact.

Our Team

Avalon SteriTech is a global start-up led by a diverse team of world-class medical doctors, biochemistry experts, along with engineering and business professionals.
Dr. Manson Fok - Chairman of the board
Dr. Manson Fok
Chairman of the board
Kenichi Yoshida - Member of Board of Directors
Kenichi Yoshida
Member of Board of Directors
Lewis Ho - Co-Founder & Chief Executive Officer
Lewis Ho
Co-Founder & Chief Executive Officer
Iris Cheng - Chief Operating Officer
Iris Cheng
Chief Operating Officer
Benny Wong - Head of HR
Benny Wong
Head of HR
Eily Cheung - Finance Director​
Eily Cheung
Finance Director​
Roger Yim​ - Senior Scientific Project Manager​
Roger Yim
Senior Scientific Project Manager​
Dr. Manson Fok - Chairman of the board
Dr. Manson Fok

Chairman of the board
MBBS, FRCS, FCHK, FHKAM

Manson is a medical doctor, entrepreneur and philanthropist. As Chairman, he is responsible for the strategic direction and general management of the Group.

Manson is the Chairman of Virtus Medical Group, one of the largest private surgical practices in Hong Kong. He also serves as Dean at the Faculty of Medicine and President of University Hospital, both at the Macau University of Science and Technology (MUST). His other positions include President of the Macau Healthcare Management and Promotion Association (MHMPA); Censor-in-Chief of the World Chinese Doctors’ Association; Honorary Fellow, Chinese College of Surgeons; and Committee member, The Council of Medical Affairs in Macau SAR.

Manson is the recipient of the 2014 Gusi Peace Prize in Humanitarianism, which was awarded for his contributions to medical education, healthcare delivery and cross-border biotechnology developments. Since 2015, he was appointed CEO of the same Peace Prize Foundation to continue promoting peace, cooperation and healthcare development in the Asia-Pacific regions.

Manson received his medical degree (MBBS) from the University of Hong Kong in 1982, where he was appointed faculty in the Surgical Unit upon graduation. He has published many original research papers in high-ranking international medical journals and chapters in various academic books focusing on minimally invasive treatment for esophageal surgery.

Kenichi Yoshida - Member of Board of Directors
Kenichi Yoshida

Board member, Avalon SteriTech
Chief Business Officer, SoftBank Robotics Corp.

Kenichi Yoshida (“Kent”) is serving as the Executive Vice President and Chief Business Officer at SoftBank Robotics, leading the SoftBank robotic project for the past 4 years since the beginning of the project. Prior to joining SoftBank Corp. he was a co-founder and COO of an enterprise software startup company called Realcom and led the company to IPO.

Kent has been working at starting new businesses in SoftBank Corp. since 2010.
Lewis Ho - Co-Founder & Chief Executive Officer
Lewis Ho

Co-Founder & Chief Executive Officer, Avalon Steritech
LLB

Lewis joined Avalon in 2019. As Senior Vice President, he oversees the strategic direction and commercialization efforts of public health and infection control technologies. He co-founded Avalon Steritech and has served as Chief Executive Officer from its inception. He is currently leading the Company’s landmark developments including the Joint Venture with SoftBank Robotics and collaboration with MTRC.

As one of Asia’s leading IP and transactional attorneys specializing in the technology and life sciences sectors, Lewis has a strong track record in helping companies and their financial sponsors capture, manage, risk assess, evaluate and monetize their intellectual property assets.

Since 2017, Lewis has been appointed as a domain expert for Hong Kong Science & Technology Park and business advisor to Beyond Ventures.
Iris Cheng - Chief Operating Officer
Iris Cheng

Chief Operating Officer
BSc, MA, MBA

As Chief Operating Officer of Avalon Steritech, Iris oversees the day-to-day business operations of the company. She aligns priorities and ensures that the organization, including its R&D, production, procurement and supply chain functions, has the necessary connectivity and coordination to accelerate innovation and growth across all markets.

Iris has more than 15 years of experience in advanced technology, materials and engineering sectors. Prior to joining Avalon in 2021, Iris served as Corporate Development Director at Lee Kee Group, a HK-listed non-ferrous metal corporation, where she was responsible for developing and executing new ventures and transformational initiatives. Before that, Iris held leadership positions at industry leaders such as Flextronics (Global 500), Johnson Electric, and Nano and Advanced Materials Institute, and has experience across a wide range of disciplines from strategic marketing and business development to technology assessments to modelling and analytics as well as platform development.

Iris holds a B.A. in Social Sciences from the University of Hong Kong, an M.A. in Arts from the University of Chicago and an MBA from London Business School.
Benny Wong - Head of HR
Benny Wong

Head of Human Resources
MA

Benny oversees Human Resources & Administration at Avalon SteriTech. Her role also covers the team of IT professionals who provide services and support to the company.

Benny has 15 years of experience in human resources across industries ranging from electronics to biotechnology to chemical and media.

Benny holds a Bachelor’s degree in Psychology from Brigham Young University Hawaii and a Master’s degree in Counselling from the City University of Hong Kong.
Jade Chui-Director, Corporate Strategy & Marketing
Jade Chui

Director, Corporate Strategy & Marketing
BSc

Jade is Director, Corporate Strategy and Marketing and since joining the Group in 2020, she has been responsible for spearheading its corporate marketing, communications and branding functions.

With more than a decade of experience in corporate strategy, Jade specializes in corporate communications, brand building, crisis and situation management, stakeholder engagement, branding and product marketing.

Prior to Avalon, Jade worked with Brunswick Group, where she advised many Asian conglomerates, family businesses and entrepreneurs on business-critical issues; key projects include Melco Resorts, MTR, New World Development and successful listing of Budweiser APAC. Prior to that, she worked at Anbang Insurance Group, a leading Asian financial institution, where she played a key role in advisory of various landmark global transactions and integration projects. Jade started her career at Wonderful Sky, where she held account servicing and strategic planning roles in investors relations and public relations for IPO and listed companies.

Jade holds a bachelor’s degree in communications from California Polytechnic University, Pomona. She speaks fluent English, Mandarin and Cantonese.
Eily Cheung - Finance Director​
Eily Cheung

Finance Director
BCom

Eily joined Avalon Sterich as Finance Director in March 2021 and is responsible for leading the company’s finance & accounting functions. She currently oversees the company’s financial and cash flow management, in addition to building up its operational accounting system.

With solid experience across numerous Japanese and Korean MNCs, Eily is a qualified professional in accounting, taxation and financial management. Prior to joining Avalon, Eily served as Senior Accountant at Softbank Robotics, where she worked closely with her headquarter counterparts in Japan. In that role, she was responsible for all finance & accounting functions, which includes SAP system migration and the management of the company’s group reporting processes. Eily had also worked at Sojitz Group, LG Group and Hyundai Group.

Eily holds a Bachelor of Commerce in Accounting from the Curtin University of Technology, Australia and a Diploma of Commerce in Australian Institute for University Studies, Australia. She speaks fluent English, Mandarin and Cantonese.
Roger Yim​ - Senior Scientific Project Manager​
Roger Yim

Senior Scientific Project Manager
PhD

As Senior Scientific Project Manager, Roger leads the cross-functional science team at Avalon SteriTech that make use of chemical and engineering tools to develop next-generation technology in disinfection and infection control. The team also facilitate technology transfer in Avalon SteriTech, which includes innovative surface disinfection technology by autonomous systems, and durable antimicrobial technology on medical textiles.

Prior to joining Avalon in 2020, Roger worked as Technical Manager in GrafTech International Limited, a leader in the global graphite industry. He was responsible for the Asia Pacific region and contributed to multiple functional groups, ranging from field sales to business execution to quality control and production. Major projects included Hyundai, POSCO, TATA Steel, Kyoei Steel Vietnam, and InfraBuild Steel (formerly Liberty OneSteel).

Roger earned his B.Sc. and Ph.D. in Chemistry from the Chinese University of Hong Kong. His research focused on organic chemistry, polymer chemistry, and artificial molecular system.